Grow Everything reveals the world of biology as technology. Hosts Erum Khan and Karl Schmieder interview leaders and influencers biologizing industries with tools like synthetic biology, precision fermentation, bioprospecting, and more. These companies make biomaterials from waste, cosmetics that restore healthy hair and skin, and delicious cultivated foods in a bioreactor and so much more. Join us as we discuss the latest and greatest across biotech, synbio, entrepreneurship, and culture an ...
…
continue reading
The Genetic Engineering and Society (GES) Center at NC State University hosts a weekly speakers colloquium, plus periodic public lectures. Topics include agricultural biotechnology, synthetic biology (SynBio), DIYbio, gene editing, gene drives, governance & responsible innovation, public engagement, sci-art, and integrated pest management, to name a few. Learn more at go.ncsu.edu/ges and sign up for our newsletter at http://eepurl.com/c-PD_T.
…
continue reading
Translation is the process of turning basic scientific research into therapies that cure disease, new sources of energy that heal the planet, and other things that move the world forward. The Translation Podcast takes a deep dive into scientific advancements with a massive potential to improve society. We talk directly with the people advancing the science with their own hands and minds, and focus on how we can translate the science from the bench to the benefit of all. Initially centered on ...
…
continue reading
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something ...
…
continue reading
At Generation Genome, our media touches on multiple topics focusing on genetics. Some of these topics include Oncogenomics, CRISPR technologies, gene therapy, artificial intelligence, and nanotechnology.
…
continue reading
The Biotech Futurist aims to foster deep understanding and discussion about exciting hot topics in biotech at the intersection with artificial intelligence and medicine, exploring CRISPR therapeutics, neuroscience, genetic diseases, interventional genomics, machine learning in biology, behavior, neuroscience, omics, cellular recording, liquid biopsy, oncology, longevity, and more. Your host Luca Fusar Bassini, PhD student at EPFL in Switzerland, interviews an expert guest every week.
…
continue reading
1
102. Waste into WOW! Cemvita's Moji Karimi on Turning Carbon Problems into Golden Opportunities
1:12:03
1:12:03
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:12:03
Karl and Erum sit down with Moji Karimi, co-founder of Cemvita, a company innovating in carbon conversion technology. Moji shares details of Cemvita’s journey from an ambitious vision of industrial biotechnology to solutions that turn carbon emissions into valuable products. Moji talks about the science and impact of reshaping industries like energ…
…
continue reading
1
Ep167: Leslie Williams on transfer RNA therapies
1:11:28
1:11:28
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:11:28
Leslie Williams, CEO of Boston-based hC Bioscience, on developing transfer RNA therapies.Timmerman Report
…
continue reading
1
S10E7 - Alice Cheng - AI for Crisis Communication
1:00:19
1:00:19
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:00:19
AI for crisis communication: Challenges and opportunities An exploration of AI’s role in managing organization-public relationships during crises, highlighting innovative applications and the challenges of implementation. Yang (Alice) Cheng, PhD Associate Professor and University Faculty Scholar in Communications, NC State University | Profile | Re…
…
continue reading
1
S10E6 - Sara Fitzsimmons - Counting GE Chestnuts Before They Ripen
1:04:26
1:04:26
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:04:26
Fall Seminar Series GE American Chestnut: Counting Chestnuts Before They Ripen Hybrid | Explore the scientific, ethical, and environmental issues which have impacted research, release, and deregulation of a transgenic American chestnut. Sara Fern Fitzsimmons, MS Chief Conservation Officer at The American Chestnut Foundation / Penn State University …
…
continue reading
1
101. Biotech's Glow Up: How Estée Lauder is Leveling Up Skincare with Rocky Graziose
1:00:16
1:00:16
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:00:16
Rocky Graziose from Estée Lauder is here to discuss the innovative intersection of biotechnology and beauty. With a background in plant natural products chemistry, Rocky brings an insider perspective on how Estée Lauder is pushing boundaries in skincare and cosmetics. He talks about the evolution of the beauty industry and how Estée Lauder’s commit…
…
continue reading
1
100. The Genspace Genesis: How Bio Design Connects People and the Planet with Dan Grushkin
58:05
58:05
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
58:05
In this milestone 100th episode, Karl and Erum look back on collaborations like the biosecurity event with Andrew Hessel and the U.S.-India Next Gen Materials event, while also acknowledging the establishment of the Chumash Heritage National Marine Sanctuary. Erum and Karl are also joined by special guest Dan Grushkin to explore the evolving world …
…
continue reading
1
S10E5 - Erika Szymanski - Crossing Kingdoms: An Experiment in (Ir)responsible Research?
1:00:09
1:00:09
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:00:09
Crossing Kingdoms: An Experiment in (Ir)responsible Research? Zoom Only | An artist-led interdisciplinary experiment with risky science led to boundary-challenging conclusions about what responsibility looks like in responsible research. Erika Szymanski, PhD Associate Professor of Rhetoric of Science at Colorado State University | ProfileDr. Erika …
…
continue reading
1
99. Petri Dish to Podcast: How 100 Episodes Helped Us Grow (and Evolve)
25:54
25:54
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
25:54
Erum and Karl reflect on their journey of producing nearly 100 episodes over two years. They discuss the challenges of consistency, the behind-the-scenes work required, and the evolution of their podcast from a simple idea to a platform that amplifies voices in the biotech space. Highlights include their gratitude to guests and collaborators, feedb…
…
continue reading
1
Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity
1:03:35
1:03:35
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:03:35
Chris Garcia, professor at Stanford University and co-founder of several biotech startups, on using protein engineering to advance new treatments for cancer and autoimmune diseases.Timmerman Report
…
continue reading
1
98. Gotta Get Them All: bitBiome's Quest to Decode All Microbes with Yuji Suzuki
1:03:19
1:03:19
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:03:19
Yuji Suzuki shares his journey from economics to leading a biotech company at the forefront of microbial research. He explains how bitBiome is unlocking the potential of trillions of microbes using advanced sequencing technology, and how their work could reshape industries from pharmaceuticals to sustainability. Yuji also dives into the future of b…
…
continue reading
1
S10E4 - Nathan Crook - Engineering bacteria to remediate PET plastics
59:01
59:01
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
59:01
Engineering Vibrio natriegens for remediation of PET plastics Hybrid | This talk covers our recent efforts to engineer the saltwater microbe Vibrio natriegens to break down PET plastics and eat the breakdown products. Nathan Crook, PhD Assistant Professor at NC State University | ProfileDr. Crook received his B.S. in Chemical Engineering from the C…
…
continue reading
1
97. Biohacking 101: Hacking Your Way to Superhuman Performance and Living Longer
47:33
47:33
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
47:33
Karl and Erum are taking us into the world of biohacking, discussing its various definitions and practices, from simple lifestyle changes to more extreme measures like genetic modification. They dig into the growing movement toward improving health, longevity, and human performance, touching on biohacking pioneers like Brian Johnson. Their conversa…
…
continue reading
1
S10E3 - Sarah Hartley - Gene Drive Mosquitoes for Malaria Control in Uganda
1:00:59
1:00:59
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:00:59
Gene Drive Mosquitoes for Malaria Control: The Governance Challenges Zoom Only | Gene Drive Mosquitoes for Malaria Control is a short documentary film beautifully shot in Uganda, exploring Ugandan stakeholders’ hopes for gene drive mosquitoes – a radical new tool potentially offering a way to eliminate or change the mosquitoes that cause malaria. S…
…
continue reading
1
96. Brewing Medicines with Synthetic Biology: Antheia's Christina Smolke on Ending Drug Shortages
55:19
55:19
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
55:19
Karl and Erum welcome Christina Smolke, CEO of Antheia and Professor at Stanford University, to discuss the rapid changes happening in biotech, particularly focusing on the biohacking community and decentralized science (DCI). Christina is developing revolutionary ways to manufacture critical pharmaceuticals using biotechnology. They explore the in…
…
continue reading
1
Ep165: Zach Hornby on Tackling Cancer Drug Resistance
1:02:45
1:02:45
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:02:45
Zach Hornby, CEO of San Diego-based Boundless Bio, on tackling cancer drug resistance.Timmerman Report
…
continue reading
1
S10E2 - Nourou Barry - Exploring Experts’ Uncertainties in Gene Drive Technology for Agricultural Pest Control in the U.S.
1:00:42
1:00:42
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:00:42
Fall Seminar Series Exploring Experts’ Uncertainties in Gene Drive Technology for Agricultural Pest Control in the U.S.: A Qualitative Study Zoom Only | This qualitative study investigates the uncertainties and diverse perspectives of experts regarding the potential use of gene drive technology for agricultural pest control in the U.S., focusing on…
…
continue reading
1
95. Fear, Facts and Frustration: Christina Agapakis on Why Scientists Need to Speak Up
1:11:02
1:11:02
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:11:02
Christina Agapakis from Ginkgo Bioworks joins the conversation to explore the power of storytelling in science. She goes into the challenges scientists face when communicating their work to the public and the role effective messaging plays in shaping perceptions, especially around complex topics like GMOs and synthetic biology. Christina shares her…
…
continue reading
1
94. Gaming the System: NVIDIA's Vega Shah on Accelerating Biotech Breakthroughs
59:21
59:21
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
59:21
Erum and Karl sit down with Vega Shah from NVIDIA to explore the role of AI in healthcare and life sciences, and how it's driving major advances in drug discovery and biotechnology. Vega shares real-world examples, from lab-grown cotton to using AI to discover new proteins in the gut microbiome. She also discusses the challenges of modeling complex…
…
continue reading
1
S10E1 - Jason Delborne – Science Policy, Soft Power, and Responsible Development
1:03:07
1:03:07
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:03:07
Science Policy, Soft Power, and Responsible Development: Reflections on the AAAS Science & Technology Policy Fellowship at the National Nanotechnology Coordination Office Hybrid | Jason Delborne spent the 2023-24 academic year as an AAAS Science and Technology Policy Fellow in Washington, DC, working at the National Nanotechnology Coordination Offi…
…
continue reading
1
93. Houston, We Have a Protocol: NASA's Kate Rubins on Biotech in Space
46:54
46:54
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
46:54
Astronaut and molecular biologist Dr. Kate Rubins shares her groundbreaking work on the International Space Station, from being the first to conduct DNA sequencing in space to advancing biotechnology in a unique and challenging environment. Dr. Rubins explains how space affects biological processes, the tools being developed to study these effects,…
…
continue reading
1
Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients
56:39
56:39
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
56:39
Ted Love, chairman of BIO, and Dr. Alan Anderson, executive director of Sickle Forward, on how to improve quality of life for sickle cell disease patients around the world.Timmerman Report
…
continue reading
1
92. Replay: From Fungi to Fun-guy: Eben Bayer Scales Mycelium Again with Bacon at My Forest Foods
43:36
43:36
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
43:36
Eben Bayer, founder of Ecovative, delves into the transformative power of mycelium technology and its potential to reshape industries from packaging to food production. He shares his journey from a small farm in Vermont to leading a company that pioneers sustainable materials, discussing how biology can be leveraged to create regenerative, profitab…
…
continue reading
1
91. Cells Sell: Your Company Can't Ignore Biotech
44:31
44:31
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
44:31
Karl and Erum dig into the pivotal role of bio strategy in shaping the future of consumer products and sustainability. With insights into groundbreaking innovations—from Cresalon's trauma gel gaining FDA approval to Living Ink's partnership with New Balance—this discussion explores how biotech is transforming traditional industries. We also tackle …
…
continue reading
1
90. Flipping the Light Switch on Cells: Deniz Kent of Prolific Machines
1:06:09
1:06:09
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:06:09
Episode Description: Erum and Karl welcome Deniz Kent to talk about the practical and innovative ways light is being used to control cellular processes, offering new possibilities in biotechnology. From sustainable fashion to the future of biomanufacturing, they discuss topics that impact both our personal lives and the broader scientific community…
…
continue reading
1
Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases
1:08:19
1:08:19
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:08:19
Sarah Boyce, CEO of San Diego-based Avidity Biosciences, on RNA medicines for rare muscle diseases.Timmerman Report
…
continue reading
1
89. Grow Everything Live! A Spotlight on Scaling Biology with Ginger Dosier of Biomason and BIOME Consortia
52:13
52:13
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
52:13
Episode Description: Join us for an exciting live recording of the Grow Everything podcast, where we sit down with Ginger Dozier of Biomason to explore how microbes could change the world. From growing bricks to building a more sustainable future, Ginger shares her incredible journey and introduces her latest venture, BIOME Consortia, which is all …
…
continue reading
1
88. Daring Dreams and Deep Tech: The Bison Ventures Blueprint for Big Wins with Ari Wright
1:00:25
1:00:25
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:00:25
Episode Description: Karl and Erum are joined by Ari Wright from Bison VC to explore the world of biotechnology and its intersection with various industries. Ari shares her perspective on the controversial idea of the enhanced Olympics, where athletes use performance-enhancing drugs under medical supervision to push human limits. She discusses the …
…
continue reading
1
87. From Fossil Fuels to Future Foods: Australia's Brilliant Bioeconomic Makeover with GW3's Kylie Porter
1:06:23
1:06:23
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:06:23
Episode Description: Karl and Erum explore how Northern Queensland is transitioning from its historical reliance on coal mining to becoming a hub for bioeconomy. Kylie Porter, CEO of GW3 - Greater Whitsunday Alliance, shares insights on the region's rich agricultural roots, the innovative use of sugarcane in biotech, and the strategic efforts to bu…
…
continue reading
1
86. Networking Natural Selection 2.0: Next Level Biotech Networking with Karl & Erum
44:55
44:55
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
44:55
Episode Description: Karl and Erum have an informative conversation about the importance of networking. They discuss the philosophy behind building meaningful professional connections and share effective networking strategies. From insights into the concept of networking as an extension of human curiosity to tips like dividing and conquering at eve…
…
continue reading
1
Ep162: Sean McClain on AI for Biologic Drug Discovery
1:05:59
1:05:59
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:05:59
Sean McClain, CEO of Absci, on using AI to speed up biologic drug discovery.Timmerman Report
…
continue reading
1
85. Always Be Brewing: Continuous Fermentation with Cauldron's Michele Stansfield
52:51
52:51
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
52:51
Episode Description: Karl and Erum discuss the fascinating world of biomanufacturing with Michele Stansfield from Cauldron. They explore the groundbreaking potential of precision fermentation and its ability to revolutionize food, fiber, and fuel production. Michele shares insights on Cauldron’s innovative hyper fermentation technology, which offer…
…
continue reading
1
84. 4th of July Replay: The Biomanufacturing Cloud with Synonym's Edward Shenderovich * New Commentary *
53:21
53:21
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
53:21
Episode Description: Since it’s a holiday week, Karl and Erum are presenting a special replay of Edward Shenderovich’s episode. Edward Shenderovich, a seasoned entrepreneur and visionary in the biomanufacturing space, takes us through his journey into the heart of biotechnology and its potential to reshape industries. Edward discusses the inception…
…
continue reading
1
Ep161: Jeff Stein on a Long-Lasting Flu Drug
1:08:51
1:08:51
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:08:51
Jeff Stein, CEO of San Diego-based Cidara Therapeutics, on a long-lasting drug against flu.Timmerman Report
…
continue reading
1
83. Bottoms Up: Microbe Mixology with Zbiotics' Zack Abbott
1:06:38
1:06:38
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:06:38
Episode Description: Karl and Erum are exploring the world of modern probiotics with Zack Abbott, co-founder of Z Biotics. They discuss the innovative approach Z Biotics takes in engineering probiotics to offer tangible benefits, specifically focusing on their flagship product designed to alleviate the unpleasant after-effects of alcohol consumptio…
…
continue reading
1
82. Future Sci is DeSci: SVN's Michael Fischer on Memefying Science Breakthroughs
1:06:27
1:06:27
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:06:27
Episode Description: Michael Fischer dives into the transformative impact of decentralized science (DeSci) on research and data sharing. He discusses the evolution of scientific research with the integration of blockchain technology, emphasizing how it democratizes access and incentivizes participation through tokenization. Fischer introduces Water…
…
continue reading
1
Ep160: Abe Ceesay on Precision Neuroscience
1:08:48
1:08:48
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:08:48
Abe Ceesay, CEO of Boston-based Rapport Therapeutics, on a precision medicine approach to neuroscience drug discovery.Timmerman Report
…
continue reading
1
81. Microalgae Marvels: Checkerspot’s Charles Dimmler’s Super Oil for Skis, Skin and Supper
1:03:47
1:03:47
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:03:47
Episode Description: Charles Dimmler joins Karl and Erum once again to discuss the innovative intersections of biotechnology and sustainability at Checkerspot. The topics talked about range from the ethical considerations of animal testing in drug development to the revolutionary applications of CRISPR in creating more efficient drugs. Charles reco…
…
continue reading
1
80. Future Fun: A 2054 Episode Beamed to 2024
20:21
20:21
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
20:21
Episode Description: Karl and Erum transport us to the year 2054, offering a vibrant and thought-provoking portrayal of the future. They discuss advancements in AI, space travel, and biotechnology, painting a picture of a world completely evolved with rapid technological and biological innovations. From moon vacations to Mars exploration, the duo d…
…
continue reading
1
Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease
1:07:22
1:07:22
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:07:22
Jimi Olaghere is one of the first patients to have been functionally cured of sickle cell disease with a CRISPR gene-edited cell therapy.Timmerman Report
…
continue reading
1
79. Decentralize and Thrive: AthenaDAO’s Blockchain Boosts Women's Health with Laura Minquini.
1:07:41
1:07:41
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:07:41
Episode Description: Karl and Erum discuss the state of health and technology with Laura Minquini of AthenaDAO, focusing on advancements in women's health research and quantum computing. Be sure to tune in to this conversation to hear about the importance of reproductive longevity, the challenges faced in women's health research, and the role of de…
…
continue reading
1
78. From Petri to Pillar: Culturing Entrepreneurship with Tony Kulesa
1:04:49
1:04:49
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:04:49
Episode Description: Karl and Erum welcome Tony Kulesa, an engineer, investor, and entrepreneur in biotech. He’s sharing his insights on the future of biotechnology, discussing how advancements in reading and writing biology are driving significant changes in the field. Tony recounts his journey from academia to founding Petri, an incubator for bio…
…
continue reading
1
Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery
1:00:44
1:00:44
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:00:44
David Younger and Randolph Lopez, co-founders of A-Alpha Bio, on using synthetic biology and AI to discover new biologic drugs.Timmerman Report
…
continue reading
1
77. AI x Biotech, Psychedelics, Mars and more at Synbiobeta 2024!!
1:02:45
1:02:45
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:02:45
Episode Description: Karl and Erum bring you the latest innovations highlighted at SynbioBeta 2024, focusing on the exciting intersection of AI and biotechnology. Hear about the groundbreaking work from the ARC Institute in whole genome sequencing and the newest advancements in AI-driven protein synthesis that are set to change the landscape of syn…
…
continue reading
1
76. Not Boring Century of Biotech with Elliot Hershberg
56:28
56:28
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
56:28
Episode Description: Elliot Hershberg, a computational biologist, writer, and investor, joins Karl and Erum to explore the fascinating intersection of technology, biology, and philosophy. They explore the power of technology-based newsletters, the economics of fermentation, the role of AI in biology, and the future of biotech. The conversation rai…
…
continue reading
1
75. Dye Another Day: The New Way to Color Textiles with Colorifix's Orr Yarkoni
1:05:31
1:05:31
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:05:31
Episode Description: Karl and Erum welcome Orr Yarkoni, CEO and co-founder of Colorifix. He gives us a deep look into the innovative realm of biotech and sustainable dyeing practices happening at Colorifix and the impact of conventional dyeing processes on the environment. Orr introduces a groundbreaking approach that utilizes genetically modified …
…
continue reading
1
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
56:33
56:33
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
56:33
Vineeta Agarwala, general partner at A16Z's Bio & Health fund, on investing in AI for drug discovery.Timmerman Report
…
continue reading
1
74. Culturing Cures: Murali Muthuswamy’s Revolution in Living Medicines
1:12:50
1:12:50
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:12:50
Episode Description: Erum and Karl welcome renowned environmentalist, Murali Muthuswamy. He is the founder and chairman of Jananom Private Limited, founder of Elive Biotherapeutics USA, and advisor to Natural Nutrition. Murali explains the urgent and complex challenges of sustainable development. He also talks about the intricate balance required t…
…
continue reading
1
73. At the Bleeding Edge: Cresilon's Joe Landolina on Rapid Wound Care
53:41
53:41
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
53:41
Episode Description: Today’s interview is with Joe Landolina, the CEO and Co-founder of Cresilon, Inc. Karl, Erum, and Joe discuss the untapped potential of animal health markets and innovative cancer treatments. Joe shares his entrepreneurial journey from founding Cresilon, Inc. in his NYU dorm to developing Vetigel, a revolutionary product design…
…
continue reading
1
S9E10 - Barbara Herr Harthorn – Societal and ethical implications of synthetic cells
59:28
59:28
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
59:28
Final GES Colloquium podcast of Spring 2024 Investigating the societal and ethical implications of synthetic cells Barbara Herr Harthorn, PhD, Research Professor of Anthropology, University of California, Santa Barbara Profile | DOWNLOAD SEMINAR POSTER This talk introduces 3 ongoing NSF-funded collaborative interdisciplinary projects investigating …
…
continue reading
1
Ep156: David Liu on New Tools and Techniques for Biology
1:52:57
1:52:57
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
1:52:57
David Liu, professor of chemistry at Harvard University and co-founder of multiple biotech companies, including Beam Therapeutics and Prime Medicine.Timmerman Report
…
continue reading